ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maine » Internal Medicine

Top Internal Medicine Prescribers in Maine

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THOMAS MCINERNEY M.D.

Internal Medicine

4,915

$302K

432
383 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $69

DANIEL MORGENSTERN MD

Internal Medicine

4,907

$267K

341
288 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $69

BENEDICT FARINO MD

Internal Medicine

4,830

$351K

411
362 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $69

JUAN RUBERO MD

Internal Medicine

4,797

$326K

192
162 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $69

KERRY RIKER M. D.

Internal Medicine

4,764

$281K

216
187 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $69

DAVID KOFFMAN M. D.

Internal Medicine

4,747

$346K

201
144 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $69

EDMUND ERVIN MD

Internal Medicine

4,719

$309K

278
262 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $69

ARCHIBALD GREEN DO

Internal Medicine

4,717

$319K

395
317 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $69

AMY ETZWEILER MD

Internal Medicine

4,651

$323K

349
299 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $69

TIMOTHY HOWE M.D.

Internal Medicine

4,596

$293K

267
234 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $69

ROBERT FRASER DO

Internal Medicine

4,564

$371K

327
280 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$81
Average prescription price

Avg: $69

DONALD STRICKLAND M.D.

Internal Medicine

4,559

$325K

378
325 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $69

JAMES DELEHANTY M.D.

Internal Medicine

4,550

$317K

253
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $69

ANN COUGHLAN M.D.

Internal Medicine

4,547

$366K

334
296 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$81
Average prescription price

Avg: $69

KATHRYN RENSENBRINK MD

Internal Medicine

4,542

$331K

349
292 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $69

PETER GUZZETTI D.O.

Internal Medicine

4,519

$367K

373
326 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$81
Average prescription price

Avg: $69

FRANKLIN BRAGG MD

Internal Medicine

4,510

$343K

381
292 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $69

PHILIP FREDERICK MD

Internal Medicine

4,491

$368K

371
350 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$82
Average prescription price

Avg: $69

LAURIE YNTEMA MD

Internal Medicine

4,454

$301K

282
234 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $69

MICHAEL QUIGLEY MD

Internal Medicine

4,426

$385K

227
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$87
Average prescription price

Avg: $69

JOHN ERICKSON MD

Internal Medicine

4,400

$292K

254
213 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $69

HEATHER SCHWEMM MD

Internal Medicine

4,372

$316K

259
212 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $69

LLOYD VANLUNEN MD

Internal Medicine

4,332

$247K

293
237 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $69

MAHESH BORHADE MD

Internal Medicine

4,283

$177K

391
265 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $69

KEVIN DAVEY M.D.

Internal Medicine

4,279

$278K

411
267 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $69

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank